Literature DB >> 2565047

Allelotype of colorectal carcinomas.

B Vogelstein1, E R Fearon, S E Kern, S R Hamilton, A C Preisinger, Y Nakamura, R White.   

Abstract

To examine the extent and variation of allelic loss in a common adult tumor, polymorphic DNA markers were studied from every nonacrocentric autosomal arm in 56 paired colorectal carcinoma and adjacent normal colonic mucosa specimens. This analysis was termed an allelotype, in analogy with a karyotype. Three major conclusions were drawn from this analysis: (i) Allelic deletions were remarkably common; one of the alleles of each polymorphic marker tested was lost in at least some tumors, and some tumors lost more than half of their parental alleles. (ii) In addition to allelic deletions, new DNA fragments not present in normal tissue were identified in five carcinomas; these new fragments contained repeated sequences of the variable number of tandem repeat type. (iii) Patients with more than the median percentage of allelic deletions had a considerably worse prognosis than did the other patients, although the size and stage of the primary tumors were very similar in the two groups. In addition to its implications concerning the genetic events underlying tumorigenesis, tumor allelotype may provide a molecular tool for improved estimation of prognosis in patients with colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565047     DOI: 10.1126/science.2565047

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  235 in total

1.  Digital PCR.

Authors:  B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Measurement of locus copy number by hybridisation with amplifiable probes.

Authors:  J A Armour; C Sismani; P C Patsalis; G Cross
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

3.  Coculturing diverse clonal populations prevents the early-stage neoplastic progression that occurs in the separate clones.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  How many mutations does it take to make a tumor?

Authors:  C R Boland; L Ricciardiello
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  hMLH1 promoter hypermethylation in microsatellite instability-positive endometrial carcinoma. Cause or consequence?

Authors:  L H Ellenson
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

6.  Head and neck cancer and precancer: can we use molecular genetics to make better predictions?

Authors:  M Partridge
Journal:  Ann R Coll Surg Engl       Date:  1999-01       Impact factor: 1.891

7.  Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability.

Authors:  Kathryn Farrand; Lydija Jovanovic; Brett Delahunt; Bryan McIver; Ian D Hay; Norman L Eberhardt; Stefan K G Grebe
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

8.  Loss of heterozygosity on chromosome 1q in human breast cancer.

Authors:  L C Chen; C Dollbaum; H S Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinoma.

Authors:  S Markowitz; M Haut; T Stellato; C Gerbic; K Molkentin
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

10.  Deletion mapping of chromosome 8p in colorectal carcinoma and dysplasia arising in ulcerative colitis, prostatic carcinoma, and malignant fibrous histiocytomas.

Authors:  M Chang; K Tsuchiya; R H Batchelor; P S Rabinovitch; B G Kulander; R C Haggitt; G C Burmer
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.